Ozempic, initially designed for diabetes management, is reshaping the food industry by altering consumer appetites and eating habits. This shift is pushing companies to innovate, focusing on personalized, health-conscious products. Explore how the rise of GLP-1 drugs is driving the food sector toward functional, low-calorie options that align with modern wellness goals.
In the food and beverage industry, personalization is also emerging as a key trend. Consumers are demanding more control over their diets, with specific recommendations based on their health and goals. According to Innova Market Survey, 64% of global consumers demand more personalized nutrition and products, tailored to their lifestyles.
OFFICES
LONDON (UK hub): 36-40 York Wy, N1 9AB, London (UK)
BARCELONA (SP hub): Passeig del Mare Nostrum, 15, 08039, Barcelona (SP)
ROME (Satellite office): Via Marsala, 29H, 00185, Rome (IT)
SITEMAP
Copyright ⓒ 2015 – 2025 All rights reserved.
Forward Fooding Ltd
